DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cefteram
Cefteram
Supplement Ii to the Japanese Pharmacopoeia Fifteenth Edition
Consideration of Antibacterial Medicines As Part Of
WO 2010/025328 Al
Computational Antibiotics Book
Jp Xvii the Japanese Pharmacopoeia
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Revision of Precautions
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
E-Table 1. Drug Classification Category Name Generic Name
Directed Molecular Evolution of Fourth-Generation Cephalosporin Resistance in Wellington Moore Iowa State University
Extended Spectrum Beta-Lactamases
Antibiotic Classes
Stembook 2018.Pdf
Clinical Pharmacy Newsletter
(12) United States Patent (10) Patent No.: US 6,613,807 B2 Uhrich (45) Date of Patent: *Sep
WHO Recommendations for Prevention and Treatment of Maternal Peripartum Infections
6-Veterinary-Medicinal-Products-Criteria-Designation-Antimicrobials-Be-Reserved-Treatment
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Top View
Therapeutic Polyanhydride Compounds for Drug Delivery
Evaluation of Ceftriaxone Nephrotoxicity in Albino Rats M.G
Antibiotic Resistance Gene Resource and Assay List
Relationship Between Chemical Structure and the Occupational
Pharmaceutical Appendix to the Tariff Schedule 2
AMR: Antimicrobial Resistance Data Analysis
Cross-Reactivity in &Beta
NG198 Evidence Review G
Literature Search Strategy for Treatment of Stable
WHO Drug Information Vol
Tomiron Tomiron
NG198 Evidence Review F1
Mosapride Citrate Hydrate
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
(12) Patent Application Publication (10) Pub. No.: US 2011/0152311 A1 Dedhiya Et Al
(12) United States Patent (10) Patent No.: US 9.211,259 B2 Friedman Et Al
Showbroad and Potent Antibacterial Activity Against Both Aerobic and Anaerobic Gram-Positive and Gram-Negative Bacteria Including /3-Lactamase-Producing Strains
WO 2U11/132171 Al
Customs Tariff - Schedule
TABLE . Recommended Evidence-Based Management For
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Supplementary
Lactamase of Mycobacterium Fortuitum D316 to Study Potentially Poor
Global Longitudinal Assessment of 2019 Changes in Defined Daily Doses
Tomiron
(12) Patent Application Publication (10) Pub. No.: US 2004/0185097 A1 Kannan Et Al
Effect of Ceftriaxone on Isolated Smooth, Cardiac Muscles and Neuromuscular Junctions M.G
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances